Parataxis Ethereum Establishes 1 Billion Won Trust to Acquire Treasury Stock… Strengthens Shareholder Returns
First Trust Agreement for the Acquisition of Treasury Stock Since the Name Change… Continued Focus on Shareholder Returns
632,911 shares to be acquired… Based on the closing price of 1,580 won on the 18th
Accumulating Ethereum (ETH) as a Strategic Financial Asset
Holds the Largest Amount of ETH Among Listed Companies in Asia
[Edaily Reporter Lee Jeong Hun ] SINSIWAY CO., LTD.(290560), an Ethereum treasury company, announced on the 19th that it held a board meeting and decided to enter into a trust agreement for the repurchase of 1 billion won worth of its own shares to enhance shareholder value and corporate value.
The contract period is six months, from today through May 19 of next year. The number of shares scheduled for acquisition is 632,911, calculated based on the closing price of 1,580 won on the previous day, the 18th. The actual number of shares acquired may vary depending on the purchase price.
This decision marks the first trust agreement for the repurchase of treasury stock since the company’s name change and is part of its ongoing efforts to return value to shareholders, a practice that began during the Shin Si-wei era. The company entered into a 1 billion won trust agreement in December 2024 and fully canceled the 150,850 shares of treasury stock acquired through that agreement on July 3 of last year. In June 2025, the company entered into an additional trust agreement worth 500 million won and acquired 71,249 shares of treasury stock.
Pursuant to Article 341-4 of the Commercial Act, newly acquired treasury shares must, in principle, be canceled within one year of the acquisition date. The specific disposition plan for the shares to be acquired through this trust agreement will be determined in accordance with relevant laws, regulations, and procedures.
Lee Myung-hoon, CEO of Parataxis Ethereum, stated, “We have consistently practiced shareholder returns through the acquisition and cancellation of treasury stock since the ShinSiWay era, before changing our company name to the current one,” adding, “This trust agreement is also an extension of that commitment. Going forward, we will continue to prioritize enhancing shareholder value and steadily review practical shareholder return measures.”
Parataxis Ethereum operates businesses in database (DB) security and digital asset treasury (DAT). The company provides the DB access control solution “Petra” and the encryption solution “Petra Cipher.” Recently, it unveiled “Petra AI,” which features natural language access log queries, anomaly detection, and security policy recommendations.
In its DAT business, the company is accumulating Ethereum (ETH) as a strategic financial asset. Regarding this, a Parataxis Ethereum official explained, “Holding Ethereum as a financial asset secures opportunities for long-term value appreciation, and staking allows us to earn additional rewards from our holdings.” The official added, “Among U.S. DAT companies, there are examples where held ETH is utilized for staking, and the amount of ETH held per share is managed as a key metric.”
As of the 15th, the company’s ETH holdings stood at 11,729. According to public data from the cryptocurrency information platform CoinGecko, this ranks 11th among publicly listed companies worldwide and is the highest among Asian listed companies based on the same data’s location classification.
CEO Lee added, “While enhancing our competitiveness in the data security business, we are also finalizing mid- to long-term management plans for our Ethereum holdings,” and noted, “We will decide whether to adopt staking after reviewing domestic legal, accounting, and auditing requirements, as well as the risks associated with asset custody and management.”
SINSIWAY CO., LTD.(290560), an Ethereum treasury company, announced on the 19th that it held a board meeting and decided to enter into a trust agreement for the repurchase of 1 billion won worth of it…
FNC ENTERTAINMENT Co., Ltd.(173940)(FNC Entertainment, hereinafter “FNC”) is generating high expectations that its business in China will gain momentum as the likelihood of the lifting of the “ban on …
A notice announcing the lifting of the limited shipment restriction in Japan for Celltrion’s Actemra biosimilar “Aptozma” 200 mg. The notice explains, “We have decided to lift the limited shipment res…